Drug reference

pentoxifylline

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1041

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(pen-toks-if′i-lin)

PDF page 1041

Functional class

Func. class.: Hemorrheologic agent, blood viscosity reducer

PDF page 1041

Uses

USES: Treatment of intermittent claudication from chronic occlusive arterial disease of the limbs

PDF page 1041

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity to pentoxifylline, xan- thines, or any component; recent cere- bral/retinal hemorrhage

PDF page 1041

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES P Intermittent claudication Adult: PO 400 mg tid; benefit may take up to 4 wk to develop, take for ≥ 8 wk.

PDF page 1041

Available forms

Available forms: Ext rel tabs 400 mg

PDF page 1041

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

pentoxifylline

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1041

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(pen-toks-if′i-lin)

PDF page 1041

Functional class

Func. class.: Hemorrheologic agent, blood viscosity reducer

PDF page 1041

Uses

USES: Treatment of intermittent claudication from chronic occlusive arterial disease of the limbs

PDF page 1041

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity to pentoxifylline, xan- thines, or any component; recent cere- bral/retinal hemorrhage

PDF page 1041

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES P Intermittent claudication Adult: PO 400 mg tid; benefit may take up to 4 wk to develop, take for ≥ 8 wk.

PDF page 1041

Available forms

Available forms: Ext rel tabs 400 mg

PDF page 1041

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.